IP Library › Granted Patent US 10,844,092
Granted Patent B2
US 10,844,092 · App. 16/259,458 · Granted Nov 24, 2020

Peptide for promoting regeneration of dentin or dental pulp tissue

Inventors: Joohwang Park (Incheon, KR); Jihyun Lee (Seoul, KR)
Assignee: HysensBio Co., Ltd.
C07K7/06A61K8/64A61K47/62A61P19/00A61Q11/00A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,844,092
App. No.
16/259,458
Granted
Nov 24, 2020
Kind
B2
Abstract

Provided are a novel peptide, a polynucleotide encoding the peptide, an expression vector including the polynucleotide, and a pharmaceutical composition including the peptide, a quasi-drug composition including the peptide, and a health functional food composition including the peptide.

Claims (23)

1. A method of treating dentin hypersensitivity and/or promoting regeneration of dentin or dental pulp tissues of a subject in need thereof, comprising administering to the subject a composition comprising one or more of the following (i)-(iii):

(i) a peptide comprising an amino acid sequence of the following Formula 1:

K—Y—R1-R2-R3-R4-R5-R6-R7-R8   (Formula 1)

wherein R1 is arginine(R), lysine(K), or glutamine(Q);

R2 is arginine(R) or glutamine(Q);

R3, R4, and R5 are arginine(R) or lysine(K), respectively:

R6 is asparagine(N) or serine(S); and

R7 and R8 are lysine(K) or tyrosine(Y), respectively,

(ii) a polypeptide compound prepared by linking repeats of the peptide (i), and

(iii) a complex of the peptide (i) linked to a drug having a therapeutic effect on dentin or dental pulp diseases.

2. The method of claim 1 , wherein the peptide of-(i) comprises any one of the amino acid sequences of SEQ ID NOS: 1 to 96.

3. The method of claim 2 , wherein the peptide (i) has a modification selected from the group consisting of N- or C-terminal acetylation, amidation, or methylation; D-amino acid introduction; peptide bond modification selected from the group consisting of CH 2 —NH, CH 2 —S, CH 2 —S═O, CH 2 —CH 2 ; backbone modification; and side-chain modification.

4. The method of claim 2 , wherein the composition is a pharmaceutical composition and further comprises a pharmaceutically acceptable carrier, excipient, or diluent.

5. The method of claim 2 , wherein the composition is a food.

6. The method of claim 2 , wherein the composition is an oral antiseptic mouthwash, oral hygiene product, toothpaste, dental floss, or oral ointment.

7. The method of claim 2 , wherein the composition comprises the peptide of (i) and the polypeptide of (ii).

8. The method of claim 2 , wherein the composition comprises the peptide of (i) and the complex of (iii).

9. The method of claim 1 , wherein the peptide (i) has a modification selected from the group consisting of N- or C-terminal acetylation, amidation, or methylation; D-amino acid introduction; peptide bond modification selected from the group consisting of CH 2 —NH, CH 2 —S, CH 2 —S═O, CH 2 —CH 2 ; backbone modification; and side-chain modification.

10. The method of claim 1 , wherein the composition is a pharmaceutical composition and further comprises a pharmaceutically acceptable carrier, excipient, or diluent.

11. The method of claim 1 , wherein the composition is a food.

12. The method of claim 1 , wherein the composition is an oral antiseptic mouthwash, oral hygiene product, toothpaste, dental floss, or oral ointment.

13. The method of claim 1 , wherein the composition comprises the peptide of (i) and the polypeptide of (ii).

14. The method of claim 1 , wherein the composition comprises the peptide of (i) and the complex of (iii).

Priority Claims (1)
KR 10-2016-0180408 · Dec 27, 2016 · national
Continuity (2)
Division 15838957 · Dec 12, 2017
Related Publication 20190153033A1 · May 23, 2019